According to the College of American Pathologists (CAP) 2013 data, approximately 80 percent of the world’s pathologists are based in the United States. This concentration causes an increased need to access, share, and diagnose images remotely.
There are a lot of stories being written about the human papilloma virus (HPV) test that has been approved by the FDA as a primary screening tool for cervical cancer. We decided to check in with one of the leading cytopathologists in the U.S., Dr. David Wilbur, Director of Pathology Imaging (and former Director of Cytopathology), at Massachusetts General Hospital to get his perspective.
It’s interesting to look beyond the U.S. to see how global digital pathology adoption is progressing. After a three month test pilot last year (with more testing over the next ten months), University Hospitals Coventry and Warwickshire NHS Trust has launched a digital pathology system across its facility with the Omnyx Integrated Digital pathology system from GE Healthcare.
